Skip to main content

Table 1 Time-course changes of biological data in the index case

From: Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis

Day/ month

WBC count

(/mm3)

Lymphocyte count

(%)

Bilirubin (mg/dL)

ALT

(IU/L)

Triglycerides

(mg/dL)

Total

cholesterol

(mg/dL)

HDL-C (mg/dL)

LDL-C (mg/dL)

VLDL-C (mg/dL)

Lp(a)-C (mg/dL)

IgM-VCA

IgG-VCA

Anti-EBNA

23/1

10,240

67

9.9

207

360

ND

ND

ND

ND

ND

(+)

(-)

(-)

27/1

6300

73

7.1

183

367

697

18

583

93

3

ND

ND

ND

05/2

7420

59

3.8

143

1492

610

31

277

299

0

ND

ND

ND

11/2

6940

47

2.9

155

302

455

26

328

96

0

ND

ND

ND

24/2

7790

35

1.5

65

175

227

ND

ND

ND

ND

ND

ND

ND

27/3

6410

36

0.5

30

114

205

ND

ND

ND

ND

ND

ND

ND

16/4

7520

37

0.5

62

193

216

39

134

43

2

(+)

(+)

(-)

03/6

6000

38

0.3

36

147

242

ND

ND

ND

ND

(+/-)

(+)

(-)

04/8

8020

37

0.5

25

178

211

34

133

44

2

(-)

(+)

(+)

  1. Cells counts were performed in venous blood. Biochemical determinations and microbiological studies were performed in serum
  2. WBC, white blood cell count. ALT, alanine aminotransferase. VCA, Epstein-Barr virus capsid antigen. EBNA, Epstein-Barr virus nuclear antigen. HDL-C, high-density lipoprotein cholesterol. LDL-C, low-density lipoprotein cholesterol. VLDL-C, very low-density lipoprotein cholesterol. Lp(a)-C, lipoprotein-A cholesterol. Cholesterol fractions [HDL-C, LDL-C, VLDL-C, and Lp(a)-C] were measured by agarose gel electrophoresis. ND, no data available
  3. (+), positive. (-), negative. (+/-), indeterminate value
  4. The patient was treated with fenofibrate (600 mg bid, po) from 05/2 to 27/3